Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meeting
23. Januar 2020 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced...
Otonomy Initiating Phase 1/2 Clinical Trial of OTO-413 in Hearing Loss
17. September 2019 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the...
Otonomy to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Corporate Update
25. Februar 2019 16:05 ET
|
Otonomy, Inc.
SAN DIEGO, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it...
Otonomy Holds Investor and Analyst Day and Provides Corporate Update
07. Oktober 2016 08:00 ET
|
Otonomy, Inc.
SAN DIEGO, Oct. 07, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and...
Otonomy Reports Third Quarter 2015 Financial Results and Provides Corporate Update
10. November 2015 16:21 ET
|
Otonomy, Inc.
SAN DIEGO, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
Otonomy Appoints Dean Hakanson, M.D., as Chief Medical Officer
01. April 2015 07:00 ET
|
Otonomy, Inc.
SAN DIEGO, April 1, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
Otonomy Submits New Drug Application to the FDA for AuriPro(TM)
26. Februar 2015 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, Feb. 26, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
Otonomy to Present at the J.P. Morgan Healthcare Conference
06. Januar 2015 08:00 ET
|
Otonomy, Inc.
SAN DIEGO, Jan. 6, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
Otonomy Added To Russell 2000(R) Index
01. Oktober 2014 08:00 ET
|
Otonomy, Inc.
SAN DIEGO, Oct. 1, 2014 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...